Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation-Reference-Cited by-同舟云学术

Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation

Published:2023-03-07 Issue:7 Volume:72 Page:2283-2297
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Lin Yun-Shan,Chiang Shu-Fen,Chen Chia-Yi,Hong Wei-Ze,Chen Tsung-Wei,Chen William Tzu-Liang,Ke Tao-Wei,Yang Pei-Chen,Liang Ji-An,Shiau An‑Cheng,Chao K. S. Clifford^ORCID,Huang Kevin Chih-Yang^ORCID

Funder

China Medical University Hospital

Ministry of Science and Technology, Taiwan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-023-03416-4.pdf

Reference49 articles.

1. Huang CY, Chiang SF, Ke TW, Chen TW, You YS, Chen WT et al (2018) Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II-III colorectal cancer. Sci Rep 8(1):15658. https://doi.org/10.1038/s41598-018-33927-5

2. Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72(1):7–33. https://doi.org/10.3322/caac.21708

3. Adlard JW, Richman SD, Seymour MT, Quirke P (2002) Prediction of the response of colorectal cancer to systemic therapy. Lancet Oncol 3(2):75–82. https://doi.org/10.1016/s1470-2045(02)00648-4

4. McCleary NJ, Meyerhardt JA, Green E, Yothers G, de Gramont A, Van Cutsem E et al (2013) Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database. J Clin Oncol 31(20):2600–2606. https://doi.org/10.1200/JCO.2013.49.6638

5. Huang CY, Chiang SF, Ke TW, Chen TW, Lan YC, You YS et al (2018) Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+ TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapy. Cancer Immunol Immunother 67(4):551–562. https://doi.org/10.1007/s00262-017-2109-5

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Boost Infiltration and Activity of T Cells via Inhibiting Ecto-5′-nucleotidase (CD73) Immune Checkpoint to Enhance Glioblastoma Immunotherapy;ACS Nano;2024-08-16

2. Improving the efficacy of immunotherapy for colorectal cancer: Targeting tumor microenvironment-associated immunosuppressive cells;Heliyon;2024-08

3. Impact of Genomic Mutation on Melanoma Immune Microenvironment and IFN-1 Pathway-Driven Therapeutic Responses;Cancers;2024-07-17

4. Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers;npj Vaccines;2024-05-31

5. Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy;Journal for ImmunoTherapy of Cancer;2024-05